Cargando…
Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) are reaching global epidemic proportions. Lack of non-invasive diagnostic tools and effective therapies constitute two of the major hurdles for a bona fide treatment and a reversal of NASH progress...
Autores principales: | Rom, Oren, Xu, Guan, Guo, Yanhong, Zhu, Yunhao, Wang, Huilun, Zhang, Jifeng, Fan, Yanbo, Liang, Wenying, Lu, Haocheng, Liu, Yuhao, Aviram, Michael, Liu, Zhipeng, Kim, Seongho, Liu, Wanqing, Wang, Xueding, Chen, Y. Eugene, Villacorta, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444056/ https://www.ncbi.nlm.nih.gov/pubmed/30772307 http://dx.doi.org/10.1016/j.ebiom.2019.02.019 |
Ejemplares similares
-
Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021) -
Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013) -
BAF60c prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis
por: Zhao, Guizhen, et al.
Publicado: (2022) -
KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction
por: Zhao, Guizhen, et al.
Publicado: (2021) -
Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)